Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests (Q84203732)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 May 2011

Language	Label	Description	Also known as
English	Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests	scientific article published on 25 May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

vulva squamous cell carcinoma

1 reference

based on heuristic

inferred from title

Wojciech Biernat

5

object named as

Wojciech Biernat

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Katarzyna Sznurkowska

4

object named as

Katarzyna Sznurkowska

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jacek Jan Sznurkowski

1

object named as

Jacek J Sznurkowski

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Anton Żawrocki

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Janusz Emerich

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

25 May 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

122

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

307-312

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

In situ and invasive vulvar cancer incidence trends (1973 to 1987)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Epidemiology and etiology of squamous cell carcinoma of the vulva

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Local and regional recurrence of vulval cancer: management dilemmas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

CD4 T cells in tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Cervical and vulva cancer: changes in FIGO definitions of staging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Risk factors. CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.050

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.04.050

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21616522%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84203732&oldid=1626201187"